Autoplaque vs Stethee Pro 1
AI Verdict
Choose Autoplaque if…
Choose Autoplaque if you require detailed, AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. This tool is ideal for clinicians needing precise measurements and characterization of atherosclerotic plaque to aid in heart attack risk prediction and guide treatment strategies based on anatomical pathology.
View Autoplaque →Choose Stethee Pro 1 if…
Choose Stethee Pro 1 if you need an AI-enabled wireless digital stethoscope for real-time cardiac and respiratory vital sign analysis and remote patient monitoring. This system is best suited for scenarios requiring immediate auscultation, sophisticated sound amplification, and secure sharing of heart and lung sounds for enhanced diagnostics in both clinical and telemedicine settings.
View Stethee Pro 1 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Autoplaque | Stethee Pro 1 |
|---|---|---|
| Pricing | Unknown | $499 usd |
| Deployment | Workstation-based post-processing application, runs on Windows or Mac OS. | Cloud, Mobile |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Stethee Pro 1Stethee Pro 1 offers greater flexibility and real-time feedback through its wireless device, mobile application, and cloud portal, making it highly adaptable for various clinical settings, including telemedicine and point-of-care diagnostics. Autoplaque, while offering clinician-reviewable automated analysis, is workstation-based, which can be less versatile.
Clinical Value
AutoplaqueAutoplaque provides critical, objective, and quantitative data for assessing coronary artery disease and predicting heart attack risk directly from CT angiography images, a high-impact application in cardiology. While Stethee Pro 1 offers valuable real-time diagnostic aid for both cardiac and respiratory conditions, Autoplaque's specific focus on quantifying a major risk factor for acute cardiac events from imaging data provides a distinct and profound clinical impact.
Pricing & Value
Stethee Pro 1Stethee Pro 1 offers transparent pricing for its device and subscription model, allowing potential users to clearly assess its cost and value proposition. Autoplaque's undisclosed pricing makes it impossible to evaluate its cost-effectiveness or compare it directly on this dimension.
Enterprise Readiness
Stethee Pro 1Stethee Pro 1 demonstrates stronger enterprise readiness with its explicit HIPAA compliance, cloud-based platform, and mobile application, which facilitates secure data sharing and integration into modern healthcare workflows. Autoplaque's workstation-based deployment and unspecified compliance details suggest a potentially more limited or less transparent approach to enterprise-level deployment and data governance.
Innovation
Stethee Pro 1Stethee Pro 1 exhibits a broader scope of innovation by transforming a traditional diagnostic tool into a smart, connected, and data-rich system that integrates AI, real-time physiological monitoring, and environmental data. While Autoplaque's AI-driven quantitative imaging analysis is highly innovative in its domain, Stethee Pro 1's multi-faceted approach to augmenting a common clinical device for enhanced diagnostics and telemedicine stands out.
Support & Docs
Stethee Pro 1Stethee Pro 1 offers more visible and accessible support resources, including a dedicated 'Support' section on its company website with various 'Getting Started', 'Hardware', and 'Software' guides, and a direct support email. While Autoplaque's FDA documentation mentions the existence of a user manual, its public-facing support and documentation are not as readily apparent or comprehensive as those for Stethee Pro 1.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Autoplaque | Stethee Pro 1 |
|---|---|---|
| Name | Autoplaque | Stethee Pro 1 |
| Company | Cedars-Sinai Medical Center: AIM | M3DICINE Pty Ltd. |
| Primary Function | AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. | AI-enabled wireless digital stethoscope system providing real-time cardiac and respiratory vital sign analysis, advanced amplification, and secure data sharing. |
| Key Features (Specific) | AI-powered quantitative analysis of atherosclerotic plaque; Measurement of luminal stenoses; Automated vessel, plaque, and lumen segmentation. | AI-enabled wireless digital stethoscope system; Captures cardiac and respiratory vital signs in 20 seconds; Sophisticated sound amplification (up to 96x) and 5 proprietary digital filters. |
| Specialties | Cardiology, Radiology | Cardiology, Emergency Medicine, Pulmonology |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
Videos
Demos, reviews, and walkthroughs featuring Autoplaque and Stethee Pro 1.